MSR34 Forecasting the Long-Term Treatment Effect Duration of Immuno-Oncology Therapies: An Analysis of the Predictive Accuracy of Treatment Waning Methods Applied to Pembrolizumab in Non-Small Cell Lung Cancer
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1766
https://www.valueinhealthjournal.com/article/S1098-3015(22)03971-7/fulltext
Title :
MSR34 Forecasting the Long-Term Treatment Effect Duration of Immuno-Oncology Therapies: An Analysis of the Predictive Accuracy of Treatment Waning Methods Applied to Pembrolizumab in Non-Small Cell Lung Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03971-7&doi=10.1016/j.jval.2022.09.1766
First page :
Section Title :
Open access? :
No
Section Order :
11315